Atlas Trials

A Study to Learn How Nusinersen (Spinraza) Affects Participants With Spinal Muscular Atrophy (SMA) Who Took it Before or During Pregnancy And About The Health of Their Babies

Clinical trial NCT05789758 · RECRUITING

Trial details

NCT number
NCT05789758
Sponsor
Biogen
Status
RECRUITING
Study type
OBSERVATIONAL
Muscular Atrophy, Spinal
Start date
2023-12-15
Primary completion
2032-10-31
Enrollment
20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.